Who are the key players in North America Molecular Infectious Disease Testing Market industry?

The top five players in the North America Molecular Infectious Disease Testing Market include Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, and Hologic Inc. These companies offer advanced molecular diagnostics platforms and are focused on innovation, strategic partnerships, and expanding their infectious disease testing portfolios across North America.

Which segment accounted for the largest North America Molecular Infectious Disease Testing Market share?

The respiratory diseases segment, including testing for influenza, RSV, and COVID-19, accounted for the largest market share. Heightened demand during the COVID-19 pandemic and persistent influenza outbreaks have fueled robust growth in this segment, as leading companies launch multiplex assays for rapid pathogen identification.

What are the factors driving the North America Molecular Infectious Disease Testing Market?

Key drivers include increased prevalence of infectious diseases, technological advancements in PCR and NGS (next-generation sequencing), and supportive regulatory frameworks. For example, Abbott Laboratories has introduced ultra-sensitive molecular kits, enabling faster and more accurate detection and boosting market growth.

Which type accounted for the largest North America Molecular Infectious Disease Testing Market share?

PCR (Polymerase Chain Reaction) based tests represented the largest share of the North American market. These tests are favored due to their high sensitivity, specificity, and ability to deliver rapid results. Major diagnostics companies are consistently innovating within this type to enhance efficiency and broaden detection capabilities.

Home Healthcare

North America Molecular Infectious Disease Testing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Q: What is the North America Molecular Infectious Disease Testing Market growth?

The North America Molecular Infectious Disease Testing Market has witnessed significant growth, with recent estimates indicating a CAGR of approximately 7% from 2022 to 2028. Companies like Thermo Fisher Scientific are driving this growth through the launch of advanced real-time PCR and molecular diagnostic kits, addressing rising infectious disease incidences.

North America Molecular Infectious Disease Testing Market: by Type (PCR, Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others), Application (Respiratory Diseases, Hepatitis, HIV, Gastrointestinal Diseases, Hospital-Acquired Infections, Others), Distribution Channels (Hospitals, Diagnostic Laboratories, Research Institutes, Point-of-Care Testing, Retail Pharmacies, Others), Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20315

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	7640
Regions	United States, Canada, Mexico
Segments	Type: PCR, Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others; Application: Respiratory Diseases, Hepatitis, HIV, Gastrointestinal Diseases, Hospital-Acquired Infections, Others; Distribution Channels: Hospitals, Diagnostic Laboratories, Research Institutes, Point-of-Care Testing, Retail Pharmacies, Others; Technology: PCR, Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others; Organization Size: Small, Medium, Large
Players	Roche Diagnostics, Abbott Laboratories, Hologic Inc., bioMérieux, Thermo Fisher Scientific, Siemens Healthineers, Becton Dickinson and Company, Cepheid (Danaher Corporation), Qiagen, Bio-Rad Laboratories, GenMark Diagnostics, Luminex Corporation, Grifols, Diasorin, Others

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	7640
Regions	United States, Canada, Mexico
Segments	Type: PCR, Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others; Application: Respiratory Diseases, Hepatitis, HIV, Gastrointestinal Diseases, Hospital-Acquired Infections, Others; Distribution Channels: Hospitals, Diagnostic Laboratories, Research Institutes, Point-of-Care Testing, Retail Pharmacies, Others; Technology: PCR, Isothermal Nucleic Acid Amplification, DNA Microarray, Hybridization, Next-Generation Sequencing, Others; Organization Size: Small, Medium, Large
Players	Roche Diagnostics, Abbott Laboratories, Hologic Inc., bioMérieux, Thermo Fisher Scientific, Siemens Healthineers, Becton Dickinson and Company, Cepheid (Danaher Corporation), Qiagen, Bio-Rad Laboratories, GenMark Diagnostics, Luminex Corporation, Grifols, Diasorin, Others